This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug;17(4):114-5.

doi: 10.1136/ebmed-2011-100424. Epub 2012 Mar 22.

In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents

Alexander C Ford¹

Affiliations

PMID: 22440557
DOI: 10.1136/ebmed-2011-100424

Comment

In irritable bowel syndrome, antispasmodics and antidepressants improve abdominal pain and global assessment and symptom scores, but there is no evidence for the effectiveness of bulking agents

Alexander C Ford. Evid Based Med. 2012 Aug.

. 2012 Aug;17(4):114-5.

doi: 10.1136/ebmed-2011-100424. Epub 2012 Mar 22.

Author

Alexander C Ford¹

Affiliation

¹ Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK. alexf12399@yahoo.com

PMID: 22440557
DOI: 10.1136/ebmed-2011-100424

Erratum in

Evid Based Med. 2012 Dec;17(6):198

No abstract available

PubMed Disclaimer

Comment on

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Ruepert L, et al. Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3. Cochrane Database Syst Rev. 2011. PMID: 21833945 Free PMC article.

Similar articles

Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL. Lesbros-Pantoflickova D, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1253-69. doi: 10.1111/j.1365-2036.2004.02267.x. Aliment Pharmacol Ther. 2004. PMID: 15606387
The spectrum of irritable bowel syndrome: A clinical review.
Gilkin RJ Jr. Gilkin RJ Jr. Clin Ther. 2005 Nov;27(11):1696-709. doi: 10.1016/j.clinthera.2005.11.012. Clin Ther. 2005. PMID: 16368443 Review.
ACP Journal Club. Review: Antispasmodics and antidepressants were each effective in the irritable bowel syndrome; bulking agents were not.
Baicus C, Voiosu T. Baicus C, et al. Ann Intern Med. 2011 Dec 20;155(12):JC6-7. doi: 10.7326/0003-4819-155-12-201112200-02007. Ann Intern Med. 2011. PMID: 22184708 No abstract available.
Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
[No authors listed] [No authors listed] Prescrire Int. 2009 Apr;18(100):75-9. Prescrire Int. 2009. PMID: 19585728
Traditional therapies for irritable bowel syndrome: an evidence-based appraisal.
Fennerty MB. Fennerty MB. Rev Gastroenterol Disord. 2003;3 Suppl 2:S18-24. Rev Gastroenterol Disord. 2003. PMID: 12775999 Review.

See all similar articles

Cited by

Resveratrol ameliorates chronic unpredictable mild stress-induced depression-like behavior: involvement of the HPA axis, inflammatory markers, BDNF, and Wnt/β-catenin pathway in rats.
Yang XH, Song SQ, Xu Y. Yang XH, et al. Neuropsychiatr Dis Treat. 2017 Oct 27;13:2727-2736. doi: 10.2147/NDT.S150028. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 29138567 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.